High expression of DIO2, an enzyme that activates thyroid hormone in IPF lungs, and a predisposition to fibrosis among DIO2 knockout mice, led investigators to treat bleomycin treated mice with thyroid hormone or a small molecule agonist (54). Here, TG is linked to idiopathic pulmonary fibrosis.